206 related articles for article (PubMed ID: 34985967)
1. TRIB3 reduces CD8
Shang S; Yang YW; Chen F; Yu L; Shen SH; Li K; Cui B; Lv XX; Zhang C; Yang C; Liu J; Yu JJ; Zhang XW; Li PP; Zhu ST; Zhang HZ; Hua F
Sci Transl Med; 2022 Jan; 14(626):eabf0992. PubMed ID: 34985967
[TBL] [Abstract][Full Text] [Related]
2. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.
Wu XQ; Tian X; Xu FJ; Wang Y; Xu WH; Su JQ; Qu YY; Zhao JY; Zhang HL; Ye DW
Bioengineered; 2022 May; 13(5):14000-14012. PubMed ID: 35726370
[TBL] [Abstract][Full Text] [Related]
4. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
[TBL] [Abstract][Full Text] [Related]
5. TRIB3 destabilizes tumor suppressor PPARα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
Luo X; Zhong L; Yu L; Xiong L; Dan W; Li J; Ye J; Chu X; Liu C; Liu B
Life Sci; 2020 Sep; 257():118021. PubMed ID: 32621919
[TBL] [Abstract][Full Text] [Related]
6. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
7. Th17 cells inhibit CD8
Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y
J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584
[TBL] [Abstract][Full Text] [Related]
8. m
Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
[TBL] [Abstract][Full Text] [Related]
9. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
[TBL] [Abstract][Full Text] [Related]
10. CXCL10 mediates CD8
Yan W; Qiu L; Yang M; Xu A; Ma M; Yuan Q; Ma X; Liang W; Li X; Lu Y
Cancer Lett; 2023 Jul; 567():216263. PubMed ID: 37354983
[TBL] [Abstract][Full Text] [Related]
11. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.
Wang H; Zhou Y; Zhang Y; Fang S; Zhang M; Li H; Xu F; Liu L; Liu J; Zhao Q; Wang F
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383115
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling.
Liu C; Zhang W; Wang J; Si T; Xing W
Cancer Sci; 2021 Oct; 112(10):4198-4207. PubMed ID: 34375482
[TBL] [Abstract][Full Text] [Related]
13. COPS6 promotes tumor progression and reduces CD8
Du WQ; Zhu ZM; Jiang X; Kang MJ; Pei DS
Acta Pharmacol Sin; 2023 Sep; 44(9):1890-1905. PubMed ID: 37095198
[TBL] [Abstract][Full Text] [Related]
14. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW
Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103
[TBL] [Abstract][Full Text] [Related]
15. The trouble with TRIBbles: TRIB3 blocks CD8 T cell homing to colorectal cancers.
Clark RA
Sci Immunol; 2022 Feb; 7(68):eabo2990. PubMed ID: 35119938
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.
Miyoshi N; Ishii H; Mimori K; Takatsuno Y; Kim H; Hirose H; Sekimoto M; Doki Y; Mori M
Br J Cancer; 2009 Nov; 101(10):1664-70. PubMed ID: 19904274
[TBL] [Abstract][Full Text] [Related]
17. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
[TBL] [Abstract][Full Text] [Related]
18. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
[TBL] [Abstract][Full Text] [Related]
19. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
[TBL] [Abstract][Full Text] [Related]
20. Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.
Mondal D; Mathur A; Chandra PK
Biochimie; 2016 May; 124():34-52. PubMed ID: 26855171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
